2.2million is great. Recent HighlightsASX/News ReleaseAVITA Medical Third Quarter Fiscal 2019 Quarterly Cash Flow Report and Company Update • Strong U.S. product sales of A$2.2 million for third quarter of Fiscal 2019 were double second quarter sales• Ten presentations highlighting RECELL® System additional clinical and economic benefits featured at American Burn Association (ABA) 51st Annual Meeting• Japan collaboration agreement with COSMOTEC• Application to market RECELL System filed in Japan• Equity placements completed for a total of A$15.5 million in proceeds
AVH Price at posting:
38.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)